Comparison of scores for bimodality of gene expression distributions and genome-wide evaluation of the prognostic relevance of high-scoring genes

BMC Bioinformatics

Volumn 11, Issue , 2010, Pages

  Hellwig, Birte ^a   Hengstler, Jan G ^a   Schmidt, Marcus ^b   Gehrmann, Mathias C ^c   Schormann, Wiebke ^a   Rahnenführer, Jörg ^a  

^a TU DORTMUND UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c SIEMENS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIMODAL DISTRIBUTION; BREAST CANCER DATA; CLUSTER-BASED METHODS; DISTINGUISHABILITY; ENRICHMENT TYPE; HIGH-DIMENSIONAL; PROGNOSTIC SIGNIFICANCE; SURVIVAL FUNCTION;

DISEASES; NORMAL DISTRIBUTION; STATISTICS;

GENE EXPRESSION;

TUMOR MARKER;

ARTICLE; BREAST TUMOR; CLUSTER ANALYSIS; COMPARATIVE STUDY; DNA MICROARRAY; EVALUATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; GENOME; HUMAN;

BREAST NEOPLASMS; CLUSTER ANALYSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOME; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77952534179     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-11-276     Document Type: Article

References (35)

1. Schmidt M, Hasenclever D, Schaeffer M, Boehm D, Cotarelo C, Steiner E, Lebrecht A, Siggelkow W, Weikel W, Schiffer-Petry I, Gebhard S, Pilch H, Gehrmann M, Lehr HA, Koelbl H, Hengstler JG, Schuler M. Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer. Clin Cancer Res 2008, 14(18):5849-5855. 10.1158/1078-0432.CCR-08-0669, 18794096.
2. Schmidt M, Hengstler JG, von Törne C, Koelbl H, Gehrmann MC. Coordinates in the universe of node-negative breast cancer revisited. Cancer Res 2009, 69(7):2695-2698. 10.1158/0008-5472.CAN-08-4013, 19318558.
3. Schmidt M, Victor A, Bratzel D, Boehm D, Cotarelo C, Lebrecht A, Siggelkow W, Hengstler JG, Elsässer A, Gehrmann M, Lehr HA, Koelbl H, von Minckwitz G, Harbeck N, Thomssen C. Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer-comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial. Ann Oncol 2009, 20(2):258-264. 10.1093/annonc/mdn590, 18824499.
4. Hengstler JG, Lange J, Kett A, Dornhöfer N, Meinert R, Arand M, Knapstein PG, Becker R, Oesch F, Tanner B. Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer. Cancer Res 1999, 59(13):3206-3214.
5. Kristensen VN, Edvardsen H, Tsalenko A, Nordgard SH, Sørlie T, Sharan R, Vailaya A, Ben-Dor A, Lønning PE, Lien S, Omholt S, Syvänen AC, Yakhini Z, Børresen-Dale AL. Genetic variation in putative regulatory loci controlling gene expression in breast cancer. Proc Natl Acad Sci USA 2006, 103(20):7735-7740. 10.1073/pnas.0601893103, 1458617, 16684880.
6. Ertel A, Tozeren A. Switch-like genes populate cell communication pathways and are enriched for extracellular proteins. BMC Genomics 2008, 9:3. 10.1186/1471-2164-9-3, 2257939, 18177501.
7. Hartigan JA, Hartigan PM. The Dip Test of Unimodality. The Annals of Statistics 1985, 113:70-84.
8. Teschendorff AE, Naderi A, Barbosa-Morais NL, Caldas C. PACK: Profile Analysis using Clustering and Kurtosis to find molecular classifiers in cancer. Bioinformatics 2006, 22(18):2269-2275. 10.1093/bioinformatics/btl174, 16682424.
9. Wang J, Wen S, Symmans WF, Pusztai L, Coombes KR. The bimodality index: a criterion for discovering and ranking bimodal signatures from cancer gene expression profiling data. Cancer Inform 2009, 7:199-216. 2730180, 19718451.
10. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005, 310(5748):644-648. 10.1126/science.1117679, 16254181.
11. Tomlins SA, Rhodes DR, Yu J, Varambally S, Mehra R, Perner S, Demichelis F, Helgeson BE, Laxman B, Morris DS, Cao Q, Cao X, Andr'en O, Fall K, Johnson L, Wei JT, Shah RB, Al-Ahmadie H, Eastham JA, Eggener SE, Fine SW, Hotakainen K, Stenman UH, Tsodikov A, Gerald WL, Lilja H, Reuter VE, Kantoff PW, Scardino PT, Rubin MA, Bjartell AS, Chinnaiyan AM. The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell 2008, 13(6):519-528. 10.1016/j.ccr.2008.04.016, 2732022, 18538735.
12. Tibshirani R, Hastie T. Outlier sums for differential gene expression analysis. Biostatistics 2007, 8:2-8. 10.1093/biostatistics/kxl005, 16702229.
13. MacQueen JB. Some methods of classification and analysis of multivariate observations. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability 1967, 281-297.
14. Fraley C, Raftery AE. Model-Based Clustering, Discriminant Analysis and Density Estimation. Journal of the American Statistical Association 2002, 97:611-631.
15. Fraley C, Raftery AE. MCLUST Version 3 for R: Normal Mixture Modeling and Model-Based Clustering. Technical Report 504 2006, University of Washington, Department of Statistics.
16. Mächler M. diptest: Hartigan's dip test statistic for unimodality - corrected code. [R package version 0.25-2, based on Fortran and S-plus from Dario Ringach (NYU.edu)] 2009,
17. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966, 50(3):163-170.
18. Latta RB. A Monte Carlo Study of Some Two-Sample Rank Tests with Censored Data. Journal of the American Statistical Association 1981, 76(375):713-719.
19. Kellerer AM, Chmelevsky D. Small-Sample Properties of Censored-Data Rank Tests. Biometrics 1983, 39(3):675-682.
20. Holm S. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 1979, 6:65-70.
21. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (Methodological) 1995, 57:289-300.
22. Conover WJ. Practical nonparametric statistics. Wiley series in probability and statistics. Applied probability and statistics section 1999, New York: John Wiley, 3.
23. Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, Pilch H, Lehr HA, Hengstler JG, Kölbl H, Gehrmann M. The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res 2008, 68(13):5405-5413. 10.1158/0008-5472.CAN-07-5206, 18593943.
24. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4(2):249-264. 10.1093/biostatistics/4.2.249, 12925520.
25. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biology 2004, 5:R80. 10.1186/gb-2004-5-10-r80, 545600, 15461798.
26. Gautier L, Cope L, Bolstad BM, Irizarry RA. affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004, 20(3):307-315. 10.1093/bioinformatics/btg405, 14960456.
27. NCBI Gene Expression Omnibus (GEO). , http://www.ncbi.nlm.nih.gov/geo/
28. Wang Y, Klijn JGM, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov D, Timmermans M, van Gelder MEM, Yu J, Jatkoe T, Berns EMJJ, Atkins D, Foekens JA. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005, 365(9460):671-679.
29. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, Fox EA, Silver PA, Gingeras TR, Liu XS, Brown M. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 2006, 38(11):1289-1297. 10.1038/ng1901, 17013392.
30. Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, Haibe-Kains B, Viale G, Delorenzi M, Zhang Y, d'Assignies MS, Bergh J, Lidereau R, Ellis P, Harris AL, Klijn JGM, Foekens JA, Cardoso F, Piccart MJ, Buyse M, Sotiriou C, . Consortium TRANSBIG Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 2007, 13(11):3207-3214. 10.1158/1078-0432.CCR-06-2765, 17545524, Consortium TRANSBIG.
31. Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, Gillet C, Ellis P, Harris A, Bergh J, Foekens JA, Klijn JGM, Larsimont D, Buyse M, Bontempi G, Delorenzi M, Piccart MJ, Sotiriou C. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol 2007, 25(10):1239-1246. 10.1200/JCO.2006.07.1522, 17401012.
32. Loi S, Haibe-Kains B, Desmedt C, Wirapati P, Lallemand F, Tutt AM, Gillet C, Ellis P, Ryder K, Reid JF, Daidone MG, Pierotti MA, Berns EM, Jansen MP, Foekens JA, Delorenzi M, Bontempi G, Piccart MJ, Sotiriou C. Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC Genomics 2008, 9:239. 10.1186/1471-2164-9-239, 2423197, 18498629.
33. Srivastava DS, Mandhani A, Mittal RD. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India. Arch Toxicol 2008, 82(9):633-639. 10.1007/s00204-007-0276-4, 18200441.
34. Wong RH, Hu CW, Yeh CY, Chao MR, Chen CC, Huang JH, Chang SH, Lee SI, Lee HS. Sulfotransferase 1A1 and glutathione S-transferase P1 genetic polymorphisms modulate the levels of urinary 8-hydroxy-2'-deoxyguanosine in betel quid chewers. Arch Toxicol 2008, 82(5):313-321. 10.1007/s00204-007-0248-8, 17912498.
35. Golka K, Blaszkewicz M, Samimi M, Bolt HM, Selinski S. Reconstruction of N-acetyltransferase 2 haplotypes using PHASE. Arch Toxicol 2008, 82(4):265-270. 10.1007/s00204-007-0247-9, 17879084.